Colombia-First Is Not a Growth Hack

Date Published

When we say "Colombia-first," some people hear a marketing story.

It's not.

It's a deliberate constraint on how we work.

Why start here

We have real relationships in Colombia. People we can talk to directly. Patients and doctors who are willing to tell us when something is confusing, overly confident, or simply not useful.

That kind of feedback is extremely rare when you're building at a distance.

Starting here also means we can move faster without pretending we have solved problems we haven't. We don't have to build for every regulatory environment at once. We can focus on making the core experience clear and honest for the people who are actually using it today.

What it means in practice

Colombia-first shapes decisions like these:

  • We are very conservative about language. If a sentence could be misread as medical advice, it gets rewritten.
  • We are not optimizing for maximum signups in month one. We're optimizing for the quality of the first few dozen real longitudinal records.
  • We are building export and data portability features earlier than a typical consumer app would, because institutional handoff is a real future scenario here.
  • We are okay with the product feeling incomplete for a long time.

This is not the fastest way to raise a big round or dominate a category. It is the fastest way for us to learn whether this tool is actually valuable to real people over months and years.

The risk we're avoiding

Many health tools launch globally with beautiful marketing and very little real-world data. They collect users quickly, then later discover that their assumptions don't hold for the people who need the tool most.

We'd rather do the opposite: start small, with people we can actually listen to, and only expand once the core thing works.

Colombia-first is our way of saying: we are not in a hurry to be everywhere. We are in a hurry to be right for the people we can serve well right now.

If that eventually leads to something bigger, great. If it stays relatively small but genuinely useful to the people using it, that's also success.

We're comfortable with either outcome.